📈

LeMaitre Vascular, Inc.

LMATDividend Contender • 14yrs
Healthcare · Medical Instruments & Supplies🇺🇸 United States
$84.45
Dividend Yield1.18%
Annual Dividend$1.00
Ex-Dividend DateAug 20, 2026
Market Cap$1.91B
100/ 100
Financial Health
Healthy
Well-covered payout (32%)Conservative leverage (D/E 0.5x)Strong ROE (17%)Revenue growing (10%)

Automated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.

At a glance

LeMaitre Vascular, Inc. (LMAT) operates in the Medical Instruments & Supplies industry and is based in the United States. It pays a quarterly dividend of $1.00 a year, a yield of 1.18% at the current price of $84.45. LeMaitre Vascular has raised its dividend for 14 consecutive years, which makes it a Dividend Contender. Over the last five years the dividend has grown by an average of 16.1% a year. It paid out 32% of its earnings as dividends, leaving most of its profit in the business. 8 analysts cover it; their average 12-month price target of $107.00 is 26.7% above the current price.

Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.

Price History
Dividend payment dates
Analyst Consensus
Buy
Bullish sentiment
50% of 8 analysts bullish
12-Month Price Target
$107.00
+26.7% vs current price

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services.

Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.

Key Metrics

Valuation

P/E Ratio
29.4
P/B Ratio
4.55
EV/EBITDA
20.8
Beta
0.47
vs S&P 500
52W High
$118.01
52W Low
$78.22

Profitability

Gross Margin
71.87%
Operating Margin
28.98%
Net Margin
25.02%
ROE
16.77%
Free Cash Flow
$49.3M

Financial Health

Debt / Equity
45.26
lower is safer
Current Ratio
16.31
>1 healthy
Quick Ratio
13.76
>1 healthy
Employees
646
HQ
Burlington, MA, United States
Data: Yahoo Finance (yfinance)|Updated: Oct 24, 2026 11:38

Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.

Legal Disclaimer

This website is not a financial advisor, investment advisor, or financial services provider. We do not offer, recommend, or imply any investment advice of any kind. We do not receive compensation, commissions, or any other benefit from any company, fund, financial product, or third party featured on this site. No content on this website constitutes a recommendation or solicitation to buy, sell, or hold any security or financial instrument.

All financial analysis, ratios, and written commentary are provided for educational and informational purposes only. The Financial Analysis and Financial Investigation sections reflect automated computations applied to publicly available financial data — they do not represent the opinion of a licensed financial professional. Always conduct your own independent research and consult a qualified, regulated financial adviser before making any investment decision. Past performance of dividends, prices, or earnings is not a guarantee of future results.

Data Sources: Yahoo Finance via yfinance (real-time prices, dividend history, financial statements, analyst ratings and price targets) · S&P 500 Dividend Aristocrats Index (official constituent list) · Dividend Kings public records (companies with 50+ years of consecutive dividend increases) · SEC EDGAR company filings (10-K annual reports — primary source for all financial statement data). Data is fetched automatically each day and may be delayed up to 24 hours. All figures are in USD unless otherwise stated.